A●●●●●● year order mobic ●●●●●● Given its well-known ●●●●●●ms, ●●●●●●or ●●●●●●●●●●●● for AstraZeneca are the ●●●●●● among all major ●●●●●●kers, with the ●●●●●● ●●●●●●g at just 10 times this year's ●●●●●●ed ●●●●●●gs, ●●●●●●t more than 16 times for Roche.
